NCT05965518

Brief Summary

This is a single site, randomized exercise trial with individuals at least 50 years of age living with HIV who experience suboptimal cognition. The overall goals of this proposal are to determine whether 16 weeks of structured high-intensity interval training (HIIT) can overcome vascular and cognitive impairments (Aim 1) to a greater extent than continuous moderate exercise. Additionally, investigator will seek to identify barriers to engagement in exercise and the participants' perceptions of the study and exercise interventions (Aim 2). This study will enroll 60 participants in Birmingham, Alabama. Data collection will occur at each visit, with baseline data collected at the initial visit with a 3-month follow-up occurring following completion of the intervention.

Trial Health

77
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
60

participants targeted

Target at below P25 for not_applicable hiv

Timeline
32mo left

Started Feb 2024

Longer than P75 for not_applicable hiv

Geographic Reach
1 country

1 active site

Status
recruiting

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Progress47%
Feb 2024Dec 2028

First Submitted

Initial submission to the registry

July 19, 2023

Completed
9 days until next milestone

First Posted

Study publicly available on registry

July 28, 2023

Completed
6 months until next milestone

Study Start

First participant enrolled

February 5, 2024

Completed
4.8 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

December 1, 2028

Expected
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

December 1, 2028

Last Updated

August 8, 2025

Status Verified

August 1, 2025

Enrollment Period

4.8 years

First QC Date

July 19, 2023

Last Update Submit

August 4, 2025

Conditions

Outcome Measures

Primary Outcomes (2)

  • Change in vascular function

    Arterial stiffness is a continuous measure of cardiovascular disease risk.

    Baseline, Up to 16 weeks, 3-months Post-Intervention

  • Change in cognitive function

    Cognitive function will be measured using BRACE+, a neuropsychological battery

    Baseline, Up to 16 weeks, 3-months Post-Intervention

Secondary Outcomes (2)

  • Barriers to Engagement in Exercise

    Baseline

  • Perceptions of the Study and Exercise Interventions

    Up to 16 weeks

Other Outcomes (1)

  • Participant Safety, Adherence to the Intervention, Retention

    Through study completion, an average of 6 months

Study Arms (2)

High-Intensity Interval Training

EXPERIMENTAL
Behavioral: High-Intensity Interval Training

Continuous Moderate Exercise

ACTIVE COMPARATOR
Behavioral: Continuous Moderate Exercise

Interventions

Following a 5-minute warm-up at 50% VO2peak, high and moderate-intensity exercise bouts alternate, progressing to five bouts of 4-minute high-intensity exercise (90% VO2peak), alternating with four 3-minute bouts of moderate-intensity exercise (50% VO2peak) by week 8, followed by a 5 minute cool-down. The total exercise time is 42 minutes.

High-Intensity Interval Training

Following a 4 minute warm-up at 50% VO2peak, the participant walks for up to 42 continuous minutes at 60% VO2peak, followed by a 4 minute cool-down. The total exercise time is 50 minutes.

Continuous Moderate Exercise

Eligibility Criteria

Age50 Years+
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • Age 50 years and older
  • Sedentary lifestyle, defined as \< 150 min/wk moderate physical activity as assessed by CHAMPS questionnaire
  • Neurocognitive Impairment (as assessed using the BRACE+
  • Prescribed HIV ART for ≥ 12 months, with no current use of older drugs with established mitochondrial toxicity
  • Able to speak, read, and write in English
  • Willingness to participate in all study procedures

You may not qualify if:

  • Diagnosis of mitochondrial disease
  • Active substance abuse or factors preventing compliance or safety
  • Uncontrolled hypertension, defined as resting BP \> 150/90 mmHG
  • Chronic kidney disease
  • Severe cardiac disease, including NYHA Class III or IV congestive heart failure, clinically significant aortic stenosis, history of cardiac arrest, use of a cardiac defibrillator, or uncontrolled angina
  • Acute myocardial infarction identified by medical history and ECG
  • Pulmonary disease requiring the use of supplemental oxygen
  • Poorly controlled diabetes
  • Neuropsychologically Intact
  • Orthopedic problems that limit ability to perform exercise
  • Simultaneous participation in another intervention trial

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

University of Alabama at Birmingham

Birmingham, Alabama, 35205, United States

RECRUITING

Related Publications (1)

  • Jones R, Hankes MJ, Vickers JK, Kulik GL, Jankowski CM, Oliveira V, Khuu V, Cook PF, Li P, Vance DE, Ivankova NV, Erlandson KM, Webel AR, Buford TW, Fazeli PL. Examining High-Intensity Exercise on Cognitive and Vascular Outcomes in Older Adults Living With HIV-A Research Protocol: Design and Rationale From Two Harmonized Clinical Studies in the Deep South. J Assoc Nurses AIDS Care. 2026 Jan-Feb 01;37(1):118-132. doi: 10.1097/JNC.0000000000000591. Epub 2025 Oct 1.

MeSH Terms

Conditions

Cognitive Dysfunction

Interventions

High-Intensity Interval Training

Condition Hierarchy (Ancestors)

Cognition DisordersNeurocognitive DisordersMental Disorders

Intervention Hierarchy (Ancestors)

Physical Conditioning, HumanExerciseMotor ActivityMovementMusculoskeletal Physiological PhenomenaMusculoskeletal and Neural Physiological Phenomena

Study Officials

  • Raymond Jones, Ph.D.

    University of Alabama at Birmingham

    PRINCIPAL INVESTIGATOR

Central Study Contacts

Raymond Jones, Ph.D.

CONTACT

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
NONE
Purpose
OTHER
Intervention Model
PARALLEL
Model Details: Participants will be randomized to high-intensity interval training or continuous moderate exercise for 12 weeks.
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Assistant Professor

Study Record Dates

First Submitted

July 19, 2023

First Posted

July 28, 2023

Study Start

February 5, 2024

Primary Completion (Estimated)

December 1, 2028

Study Completion (Estimated)

December 1, 2028

Last Updated

August 8, 2025

Record last verified: 2025-08

Data Sharing

IPD Sharing
Will share

Participant-level deidentified data will be preserved through deposition of the data in a controlled public repository. All aggregate datasets that can be shared publicly will be deposited in the NIH/NIA Repository, National Archive of Computerized Data on Aging (NACDA).

Shared Documents
STUDY PROTOCOL, SAP, ICF
Time Frame
Data will be made available no later than the time of an associated publication or end of the funding period, whichever comes first. NACDA guarantees data will be made available for ≥10 years
Access Criteria
De-identified individual participant data will be deposited into NACDA as restricted, which limits access to the data to qualified investigators with who must sign a data use agreement. NACDA requires users to submit a data use agreement. NACDA will review the data request for completeness and determine if an IRB approval is needed. Anyone who has submitted an approved data request and signed data use agreement on NACDA will be given access to the data without cost, for a set period.

Locations